Exchange: NASDAQ·Updated 04:10 PM EDT
DBVT logo

DBVT DBV Technologies

$12.35
$0.16
(1.28%)
Today
Closed $12.35
$0.00
(0.00%)
After Hours
EarningsOct 28
Mkt Cap$776.18M
Vol137,641.00

About DBVT

DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk, as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont, and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Chatillon, France.
61

Bullish Sentiment

How do you feel about DBVT?

Advertisement|Remove ads.